NEJM published new treatment for ACEI-induced Angioedema. This study funded by Shire (a Biopharmaceuticals Company) and the Federal Ministry of Education and Research of Germany. Icatibant with generic name of FIRAZYR was administrated to 27 patients with ACEI angioedema in the setting of double blind, randomised phase 2 study. As we know the usual treatment … Continue reading New Drug for ACE-Inhibitor–Induced Angioedema!